Background Four formulations of Tamoxifen citrate loaded polylactide-co-glycolide (PLGA)
based nanoparticles (TNPs) were developed and characterized. Their internalization by …

To increase the local concentration of tamoxifen in estrogen receptor (ER) positive breast
cancer, we have developed and characterized nanoparticle formulation using poly (ε …

The aim of the present study was to develop nanoparticles of tamoxifen citrate, a non-
steroidal antiestrogenic drug used for the treatment of breast cancer. Biodegradable poly (D …

The present investigation reports on the conditions for preparation of tamoxifen loaded
PLGA nanoparticles (Tmx-NPs) for oral administration. Tmx-NPs with> 85% entrapment …

In this study, poly (L-lactide)(PLA) nanoparticles containing Tamoxifen (Tmx) were
developed using an emulsion/solvent evaporation method, observing the influence of …

Purpose: In an attempt to increase the local concentration of tamoxifen in estrogen receptor
positive breast cancer cells, we have prepared and characterized poly (ε …

This study was carried out to evaluate and compare the biodistribution profile of tamoxifen
when administered intravenously (iv) as a simple solution or when encapsulated in …

Nanoparticulate delivery systems have been noticed for chemotherapeutical delivery due to
their ability in controlling the drug release and reducing the side effect. These systems could …

Natural polysaccharides, due to their outstanding merits, have received more and more
attention in the field of drug delivery. In the present study tamoxifen citrate, TMX (a non …

Tamoxifen (TAM), as a hydrophobic drug, is a selective estrogen modulator (SERM) applied
to hormone therapy for breast cancer (BC). Although it is effective and affordable in BC …